US5234767A
(en)
*
|
1987-03-13 |
1993-08-10 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
US5147723A
(en)
*
|
1987-07-28 |
1992-09-15 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5474848A
(en)
*
|
1987-03-13 |
1995-12-12 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
US5023086A
(en)
*
|
1987-03-13 |
1991-06-11 |
Micro-Pak, Inc. |
Encapsulated ionophore growth factors
|
US5628936A
(en)
*
|
1987-03-13 |
1997-05-13 |
Micro-Pak, Inc. |
Hybrid paucilamellar lipid vesicles
|
AU603659B2
(en)
*
|
1987-03-13 |
1990-11-22 |
Micro Vesicular Systems, Inc. |
Lipid vesicles formed of surfactants and steroids
|
US5219538A
(en)
*
|
1987-03-13 |
1993-06-15 |
Micro-Pak, Inc. |
Gas and oxygen carrying lipid vesicles
|
US5811119A
(en)
*
|
1987-05-19 |
1998-09-22 |
Board Of Regents, The University Of Texas |
Formulation and use of carotenoids in treatment of cancer
|
EP0324455A3
(de)
*
|
1988-01-15 |
1991-03-27 |
Hans O. Ribi |
Neue polymerische Immuno-Adjuvans
|
US5104736A
(en)
*
|
1988-03-03 |
1992-04-14 |
Micro-Pak, Inc. |
Reinforced paucilamellar lipid vesicles
|
US5019174A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro Vesicular Systems, Inc. |
Removing oil from surfaces with liposomal cleaner
|
US5032457A
(en)
*
|
1988-03-03 |
1991-07-16 |
Micro Vesicular Systems, Inc. |
Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants
|
US5160669A
(en)
*
|
1988-03-03 |
1992-11-03 |
Micro Vesicular Systems, Inc. |
Method of making oil filled paucilamellar lipid vesicles
|
US5019392A
(en)
*
|
1988-03-03 |
1991-05-28 |
Micro-Pak, Inc. |
Encapsulation of parasiticides
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US4895452A
(en)
*
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5510117A
(en)
*
|
1989-03-09 |
1996-04-23 |
Micro-Pak, Inc. |
Entrapment vehicle and method
|
GB8906234D0
(en)
*
|
1989-03-17 |
1989-05-04 |
Albright & Wilson |
Agrochemical suspensions
|
WO1991004013A1
(en)
*
|
1989-09-21 |
1991-04-04 |
Micro Vesicular Systems, Inc. |
Hybrid paucilamellar lipid vesicles
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
FR2657607B1
(fr)
*
|
1990-01-30 |
1992-04-30 |
Durand Muriel |
Procede de protection de la dihydroxyacetone, dihydroxyacetone protegee par ce procede et produit cosmetique contenant une telle dihydroxyacetone protegee.
|
US5213810A
(en)
*
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
US5165994A
(en)
*
|
1990-06-05 |
1992-11-24 |
University Of Delaware |
Spontaneous equilbrium surfactant vesicles
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
US6165500A
(en)
*
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
WO1992003123A1
(en)
*
|
1990-08-28 |
1992-03-05 |
Liposome Technology, Inc. |
Liposome alternative bilayer formulations
|
DE69120543T2
(de)
*
|
1990-09-06 |
1997-01-09 |
Johnson & Son Inc S C |
Verfahren zur stabilisierung von liposomen sowie diese enthaltende mittel
|
US5145604A
(en)
*
|
1990-09-19 |
1992-09-08 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aerosol delivery system using same
|
US5091111A
(en)
*
|
1990-09-19 |
1992-02-25 |
S. C. Johnson & Son, Inc. |
Aqueous emulsion and aersol delivery system using same
|
AU654858B2
(en)
*
|
1991-03-28 |
1994-11-24 |
Novavax, Inc. |
Lipid vesicle containing water-in-oil emulsions
|
US5256422A
(en)
*
|
1991-03-28 |
1993-10-26 |
Micro Vesicular Systems, Inc. |
Lipid vesicle containing water-in-oil emulsions
|
DE4121945C2
(de)
*
|
1991-07-03 |
1993-11-04 |
Merz & Co Gmbh & Co |
Verfahren zur herstellung von stabilen, hydrophilen oder ambiphilen creme-zubereitungen, enthaltend vesikulaere bestandteile, stabile creme-zubereitungen mit vesikulaeren bestandteilen und deren verwendung
|
US5213805A
(en)
*
|
1991-07-25 |
1993-05-25 |
Micro Vesicular Systems, Inc. |
Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid
|
US5643600A
(en)
*
|
1991-09-17 |
1997-07-01 |
Micro-Pak, Inc. |
Lipid vesicles containing avocado oil unsaponifiables
|
US5260065A
(en)
*
|
1991-09-17 |
1993-11-09 |
Micro Vesicular Systems, Inc. |
Blended lipid vesicles
|
US5439967A
(en)
*
|
1991-09-17 |
1995-08-08 |
Micro Vesicular Systems, Inc. |
Propylene glycol stearate vesicles
|
US5405615A
(en)
*
|
1991-09-17 |
1995-04-11 |
Micro Vesicular Systems, Inc. |
Sucrose distearate lipid vesicles
|
CA2150463A1
(en)
*
|
1992-12-02 |
1994-06-09 |
Donald F. H. Wallach |
Extended duration antacid product
|
US5393527A
(en)
*
|
1993-01-04 |
1995-02-28 |
Becton, Dickinson And Company |
Stabilized microspheres and methods of preparation
|
AU6018894A
(en)
*
|
1993-01-15 |
1994-08-15 |
Micro Vesicular Systems, Inc. |
Method of inhibiting viral reproduction
|
US5853755A
(en)
*
|
1993-07-28 |
1998-12-29 |
Pharmaderm Laboratories Ltd. |
Biphasic multilamellar lipid vesicles
|
EP0734251B1
(de)
|
1993-12-17 |
2009-10-14 |
Novavax, Inc. |
Verfahren zur übertragung eines biologisch aktiven materials an eine zelle
|
CA2183435C
(en)
*
|
1994-02-24 |
2008-05-13 |
Craig D. Wright |
Vaccines containing paucilamellar lipid vesicles as immunological adjuvants
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
US5629021A
(en)
*
|
1995-01-31 |
1997-05-13 |
Novavax, Inc. |
Micellar nanoparticles
|
FR2730928B1
(fr)
*
|
1995-02-23 |
1997-04-04 |
Oreal |
Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
|
US5599548A
(en)
*
|
1995-05-08 |
1997-02-04 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing fatty acid amides and retinol or retinyl ester
|
US5954998A
(en)
*
|
1995-05-25 |
1999-09-21 |
The Clorox Company |
Liquid peracid precursor colloidal dispersions: oil-core vesicles
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
US5834014A
(en)
*
|
1995-10-06 |
1998-11-10 |
The Regents Of The University Of Michigan |
Stimulation of hair follicles
|
US6071535A
(en)
*
|
1996-01-31 |
2000-06-06 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
US5662957A
(en)
*
|
1996-05-03 |
1997-09-02 |
Novavax, Inc. |
Oil containing lipid vesicles with marine applications
|
US5700679A
(en)
*
|
1996-06-07 |
1997-12-23 |
Novavax, Inc. |
Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal activity
|
US5846551A
(en)
*
|
1996-06-10 |
1998-12-08 |
E-L Management Corp. |
Water-based makeup compositions and methods for their preparation
|
US5955092A
(en)
*
|
1996-09-27 |
1999-09-21 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
|
US5747051A
(en)
*
|
1996-09-27 |
1998-05-05 |
Elizabeth Arden Co., Division Of Conopco, Inc. |
Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
|
US5935572A
(en)
*
|
1997-01-10 |
1999-08-10 |
Collaborative Laboratories, Inc. |
Composition containing protease separate from glycosidase for removing nits in treating lice infestation
|
US6039960A
(en)
|
1997-05-28 |
2000-03-21 |
E-L Management Corp. |
Water containing wax-based product
|
IS4518A
(is)
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
US5993852A
(en)
*
|
1997-08-29 |
1999-11-30 |
Pharmaderm Laboratories Ltd. |
Biphasic lipid vesicle composition for transdermal administration of an immunogen
|
TW476788B
(en)
|
1998-04-08 |
2002-02-21 |
Kimberly Clark Co |
A cleanser and the making process thereof
|
GB9824024D0
(en)
*
|
1998-11-03 |
1998-12-30 |
Unilever Plc |
Shampoo compositions
|
CZ20012038A3
(cs)
*
|
1998-12-23 |
2001-09-12 |
Idea Ag |
Zdokonalený přípravek pro topické, neinvazivní použití in vivo
|
DK1031347T3
(da)
|
1999-01-27 |
2002-07-08 |
Idea Ag |
Transnasal transport/immunisering med meget tilpasselige bærere
|
ES2173678T3
(es)
|
1999-01-27 |
2002-10-16 |
Idea Ag |
Vacunacion no invasiva a traves de la piel.
|
US6080211A
(en)
|
1999-02-19 |
2000-06-27 |
Igen, Inc. |
Lipid vesicle-based fuel additives and liquid energy sources containing same
|
CA2309373A1
(en)
*
|
1999-05-27 |
2000-11-27 |
Johnson & Johnson Consumer Companies, Inc. |
Novel topical formulations
|
MXPA02000053A
(es)
*
|
1999-07-05 |
2003-07-21 |
Idea Ag |
Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
|
US6309664B1
(en)
|
1999-09-15 |
2001-10-30 |
Igen, Incorporated |
Methods, uses and compositions of fluid petrolatum
|
US6534078B1
(en)
*
|
1999-10-18 |
2003-03-18 |
Natural Pest Fx, Inc. |
Micro-encapsulated pepper-mustard composition and methods of using the same
|
US6375968B1
(en)
|
1999-10-22 |
2002-04-23 |
3M Innovative Properties Company |
Encapsulated active material immobilized in hydrogel microbeads
|
US6376514B1
(en)
|
2000-10-17 |
2002-04-23 |
The Procter & Gamble Co. |
Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
|
US6540991B2
(en)
|
2001-04-06 |
2003-04-01 |
3M Innovative Properties Company |
Stabilized active materials
|
US6562361B2
(en)
|
2001-05-02 |
2003-05-13 |
3M Innovative Properties Company |
Pheromone immobilized in stable hydrogel microbeads
|
AU2002353774A1
(en)
*
|
2001-08-01 |
2003-03-24 |
The Procter And Gamble Company |
Products and methods for treating microbial infections
|
WO2003016350A1
(en)
*
|
2001-08-16 |
2003-02-27 |
Lyfjathroun H.F., Biopharmaceuticals |
A method of producing antibodies ex-vivo
|
US6709663B2
(en)
*
|
2001-08-31 |
2004-03-23 |
Healthpoint, Ltd. |
Multivesicular emulsion drug delivery systems
|
DE60137229D1
(de)
*
|
2001-10-22 |
2009-02-12 |
Viroblock Sa |
Non-phospholipid Vesikel (npLV) und ihre Verwendung in kosmetischen, therapeutischen und prophylaktischen Anwendungen
|
US20030129213A1
(en)
*
|
2001-12-26 |
2003-07-10 |
Gonzalez Anthony D. |
Meta-stable insect repellent emulsion composition and method of use
|
US20030219465A1
(en)
*
|
2002-05-23 |
2003-11-27 |
Suresh Kumar Gidwani |
Composition for delivery of dithranol
|
US20030232091A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Adi Shefer |
Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
|
US20040105881A1
(en)
*
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
WO2009012489A1
(en)
|
2007-07-19 |
2009-01-22 |
Novavax, Inc. |
Avian influenza chimeric vlps
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
CN101579529A
(zh)
*
|
2003-09-29 |
2009-11-18 |
托皮根药品公司 |
治疗包括炎症状况的疾病的寡核苷酸组合物和方法
|
EP1754532B1
(de)
|
2004-04-05 |
2018-06-20 |
Kanagawa University |
Emulgierend wirkende dispergiermittel, verfahren zum emulgieren und dispergieren damit, emulsionen und emulsionsbrennstoffe
|
US8034796B2
(en)
*
|
2004-04-07 |
2011-10-11 |
The University Of Georgia Research Foundation, Inc. |
Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
|
MXPA06011475A
(es)
|
2004-04-07 |
2007-04-25 |
Univ Georgia Res Found |
Profarmacos, composiciones y metodos mutuos de glucosamina y glucosamina/antiinflamatorios.
|
JP4616602B2
(ja)
*
|
2004-09-16 |
2011-01-19 |
大日本塗料株式会社 |
単分散粒子の製造方法
|
RU2416412C2
(ru)
*
|
2004-10-29 |
2011-04-20 |
Топиджен Фармасьютикалз Инк. |
Антисмысловые олигонуклеотиды для лечения аллергии и пролиферации неопластических клеток
|
JP2008519784A
(ja)
*
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
JP4533420B2
(ja)
*
|
2004-12-22 |
2010-09-01 |
日東電工株式会社 |
線維化抑制のための薬物担体および薬物担体キット
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
DK1842557T3
(da)
|
2004-12-22 |
2013-12-02 |
Nitto Denko Corp |
Lægemiddelbærer og lægemiddelbærerkit til inhibition af fibrose
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
EP1852177B1
(de)
|
2005-01-28 |
2014-02-26 |
Japan Science and Technology Agency |
Molekulares aggregat, das dazu befähigt ist, eine phasenumwandlung durch dehydratisierende kondensation zu durchlaufen, und verfahren zur phasenumwandlung davon
|
US7470787B2
(en)
|
2005-07-11 |
2008-12-30 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
EP1951762B1
(de)
*
|
2005-10-03 |
2018-02-07 |
PINSKY, Mark A. |
Zusammensetzungen und verfahren zur verbesserten hautpflege
|
SG2014012868A
(en)
|
2005-10-18 |
2014-09-26 |
Novavax Inc |
Functional influenza virus like particles (vlps)
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
EP2019835A4
(de)
*
|
2006-05-19 |
2010-08-04 |
Topigen Pharmaceuticals Inc |
Die expression von phosphodiesterasen beeinflussende oligonukleotide
|
AU2007252967B2
(en)
*
|
2006-05-19 |
2011-11-10 |
Viroblock S.A. |
A composition for inactivating an enveloped virus
|
EP2068878B1
(de)
|
2006-09-20 |
2019-04-10 |
Aerie Pharmaceuticals, Inc. |
Rho-kinase-hemmer
|
CN101610749B
(zh)
*
|
2006-12-28 |
2013-01-02 |
3M创新有限公司 |
牙科填料及方法
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
CA2675745A1
(en)
*
|
2007-01-18 |
2008-07-24 |
Mark A. Pinsky |
Materials and methods for delivering antioxidants into the skin
|
TWI407971B
(zh)
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
CA2692171C
(en)
|
2007-06-22 |
2019-10-22 |
Randolph Watnick |
Methods and uses thereof of prosaposin
|
FR2917976B1
(fr)
*
|
2007-06-29 |
2010-05-28 |
Galderma Sa |
Composition dermatologique comprenant des vehicules lipidiques de calcitriol, son procede de preparation et son utilisation
|
AU2008345068A1
(en)
*
|
2007-12-26 |
2009-07-09 |
Mark A. Pinsky |
Collagen formulations for improved skin care
|
US8455514B2
(en)
*
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
US10251839B2
(en)
*
|
2008-01-22 |
2019-04-09 |
Igi Laboratories, Inc. |
Lipid vesicles derived from olive oil fatty acids
|
AU2009246000B2
(en)
|
2008-05-15 |
2014-09-04 |
Topigen Pharmaceuticals Inc. |
Oligonucleotides for treating inflammation and neoplastic cell proliferation
|
EP2294178B1
(de)
|
2008-05-23 |
2014-07-16 |
Siwa Corporation |
Verfahren zur regenerationserleichterung
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
US20110229544A1
(en)
*
|
2008-11-26 |
2011-09-22 |
Viroblock S.A. |
Methods for Inhibiting Gram-Postive Bacteria Using Non-Phospholipid Lipid Vesicules
|
DK3067064T3
(da)
|
2008-12-09 |
2020-06-08 |
Novavax Inc |
Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
|
CA2929545C
(en)
|
2009-05-01 |
2019-04-09 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|
EP3871671A3
(de)
|
2009-07-29 |
2022-03-09 |
Olsen, Elise |
Fp rezeptorantagonisten zur hemmung von haarwachstum
|
CA2781529C
(en)
*
|
2009-09-23 |
2017-10-24 |
Indu Javeri |
Methods for the preparation of liposomes comprising docetaxel
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
EP3366695B1
(de)
|
2009-12-17 |
2021-07-07 |
Children's Medical Center Corporation |
Aus saposin-a gewonnene peptide und verwendungen davon
|
ES2725852T3
(es)
|
2010-09-27 |
2019-09-27 |
Siwa Corp |
Eliminación selectiva de células modificadas por AGE para el tratamiento de la aterosclerosis
|
SI2635257T1
(en)
|
2010-11-05 |
2018-01-31 |
Novavax, Inc. |
Particles as rabies virus glycoproteins
|
US8721571B2
(en)
|
2010-11-22 |
2014-05-13 |
Siwa Corporation |
Selective removal of cells having accumulated agents
|
WO2012075337A2
(en)
|
2010-12-01 |
2012-06-07 |
Spinal Modulation, Inc. |
Directed delivery of agents to neural anatomy
|
EP2720721B1
(de)
|
2011-06-17 |
2017-08-30 |
President and Fellows of Harvard College |
Frizzled 2 als zielmolekül für therapeutische antikörper bei der behandlung von krebs
|
EP2726071B1
(de)
|
2011-06-29 |
2023-10-11 |
Avidas Pharmaceuticals LLC |
Topische formulierungen mit lipidmikrokapsel-abgabemitteln und ihre verwendungen
|
EP3613852A3
(de)
|
2011-07-22 |
2020-04-22 |
President and Fellows of Harvard College |
Beurteilung und verbesserung einer nukleasespaltungsspezifität
|
WO2013096868A2
(en)
|
2011-12-22 |
2013-06-27 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
US9737480B2
(en)
|
2012-02-06 |
2017-08-22 |
President And Fellows Of Harvard College |
ARRDC1-mediated microvesicles (ARMMs) and uses thereof
|
JP6492003B2
(ja)
|
2012-03-30 |
2019-03-27 |
ワシントン・ユニバーシティWashington University |
発作を減少させるためおよび神経変性症候群を改質するためにタウ発現を調節する方法
|
CA2906119A1
(en)
|
2013-03-14 |
2014-09-25 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for modulating tau expression
|
WO2014152511A1
(en)
|
2013-03-15 |
2014-09-25 |
The Jackson Laboratory |
Methods for promoting wound healing and hair growth
|
CN109528721B
(zh)
|
2013-03-15 |
2021-10-01 |
爱瑞制药公司 |
联合治疗
|
US20140325490A1
(en)
*
|
2013-04-25 |
2014-10-30 |
Hewlett-Packard Development Company, L.P. |
Classifying Source Code Using an Expertise Model
|
TWI772856B
(zh)
|
2013-07-19 |
2022-08-01 |
美商百健Ma公司 |
用於調節τ蛋白表現之組合物
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
KR102399854B1
(ko)
|
2013-09-19 |
2022-05-19 |
노바백스, 인코포레이티드 |
면역원성 중동호흡기증후군 코로나바이러스 (ΜERS-CoV) 조성물 및 방법
|
US9068179B1
(en)
|
2013-12-12 |
2015-06-30 |
President And Fellows Of Harvard College |
Methods for correcting presenilin point mutations
|
RU2016122918A
(ru)
*
|
2013-12-23 |
2018-01-30 |
Дэрмопартнерс, С.Л. |
Способ получения липосом ретинальдегида или других предшественников ретиноевой кислоты и образующийся таким образом продукт
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
SG11201701423RA
(en)
|
2014-09-03 |
2017-03-30 |
Boehringer Ingelheim Int |
Compound targeting il-23a and tnf-alpha and uses thereof
|
RU2721568C2
(ru)
|
2014-09-19 |
2020-05-20 |
Сива Корпорейшн |
Анти-age антитела для лечения воспаления и аутоиммунных нарушений
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
US9993535B2
(en)
|
2014-12-18 |
2018-06-12 |
Siwa Corporation |
Method and composition for treating sarcopenia
|
US10358502B2
(en)
|
2014-12-18 |
2019-07-23 |
Siwa Corporation |
Product and method for treating sarcopenia
|
WO2016138287A1
(en)
|
2015-02-25 |
2016-09-01 |
Washington University |
METHODS TO DETECT MOTOR NEURON DISEASE COMPRISING MICRO-RNAs
|
JP6866345B2
(ja)
|
2015-07-23 |
2021-04-28 |
ベーリンガー・インゲルハイム・インターナショナル・ゲーエムベーハー |
Il−23a及びb細胞活性化因子(baff)を標的とする化合物及びその使用
|
AU2016315478B2
(en)
|
2015-09-03 |
2023-07-13 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
CA3000815C
(en)
|
2015-10-13 |
2022-11-01 |
Siwa Corporation |
Anti-age antibodies and methods of use thereof
|
CN108513575A
(zh)
|
2015-10-23 |
2018-09-07 |
哈佛大学的校长及成员们 |
核碱基编辑器及其用途
|
JP6832946B2
(ja)
|
2015-11-17 |
2021-02-24 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤およびその中間体の調製方法
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
WO2017143073A1
(en)
|
2016-02-19 |
2017-08-24 |
Siwa Corporation |
Method and composition for treating cancer, killing metastatic cancer cells and preventing cancer metastasis using antibody to advanced glycation end products (age)
|
US10435682B2
(en)
|
2016-02-19 |
2019-10-08 |
University Of South Florida |
Arginine deiminase gene therapy for disordered proteins
|
KR20180133452A
(ko)
|
2016-04-15 |
2018-12-14 |
시와 코퍼레이션 |
신경퇴행성 질환을 치료하기 위한 항-노화 항체
|
CN109476713A
(zh)
|
2016-06-08 |
2019-03-15 |
儿童医学中心公司 |
工程改造的肉毒杆菌神经毒素
|
WO2017222535A1
(en)
|
2016-06-23 |
2017-12-28 |
Siwa Corporation |
Vaccines for use in treating various diseases and disorders
|
PL3481852T3
(pl)
|
2016-07-08 |
2023-07-24 |
Children's Medical Center Corporation |
Nowa neurotoksyna botulinowa i jej pochodne
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
CA3033327A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
CN106268551B
(zh)
*
|
2016-08-09 |
2018-11-20 |
中国石油大学(华东) |
一种具有光捕获功能的多级复合微胶囊的制备方法
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
JP6907319B2
(ja)
|
2016-08-31 |
2021-07-21 |
アエリエ ファーマシューティカルズ インコーポレイテッド |
眼科用組成物
|
JOP20190065A1
(ar)
|
2016-09-29 |
2019-03-28 |
Ionis Pharmaceuticals Inc |
مركبات وطرق لتقليل التعبير عن tau
|
US11730823B2
(en)
|
2016-10-03 |
2023-08-22 |
President And Fellows Of Harvard College |
Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
GB2572918B
(en)
|
2016-12-23 |
2023-02-15 |
Harvard College |
Gene editing of PCSK9
|
US10858449B1
(en)
|
2017-01-06 |
2020-12-08 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis
|
US10925937B1
(en)
|
2017-01-06 |
2021-02-23 |
Siwa Corporation |
Vaccines for use in treating juvenile disorders associated with inflammation
|
US10961321B1
(en)
|
2017-01-06 |
2021-03-30 |
Siwa Corporation |
Methods and compositions for treating pain associated with inflammation
|
US10995151B1
(en)
|
2017-01-06 |
2021-05-04 |
Siwa Corporation |
Methods and compositions for treating disease-related cachexia
|
WO2018165631A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Cancer vaccine
|
EP3592853A1
(de)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Unterdrückung von schmerzen durch geneditierung
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
SG11201908658TA
(en)
|
2017-03-23 |
2019-10-30 |
Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
AU2018243687C1
(en)
|
2017-03-31 |
2020-12-24 |
Alcon Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
EP3609923A1
(de)
|
2017-04-13 |
2020-02-19 |
Siwa Corporation |
Humanisierter monoklonaler advanced-glycation-endproduct-antikörper
|
US11560566B2
(en)
|
2017-05-12 |
2023-01-24 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
|
WO2019023196A1
(en)
|
2017-07-24 |
2019-01-31 |
Novavax, Inc. |
METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
US20200255481A1
(en)
|
2017-09-29 |
2020-08-13 |
Children's Medical Center Corporation |
Neurotoxin-like toxin and uses thereof
|
CN111757937A
(zh)
|
2017-10-16 |
2020-10-09 |
布罗德研究所股份有限公司 |
腺苷碱基编辑器的用途
|
US11541120B2
(en)
|
2017-12-05 |
2023-01-03 |
Anthos Partners, Lp |
Phosphonium-based ionic drug conjugates
|
US11518801B1
(en)
|
2017-12-22 |
2022-12-06 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
US11254704B2
(en)
|
2018-01-05 |
2022-02-22 |
University Of South Florida |
Compounds and methods for reducing or inhibiting aggregation of proteins in a subject
|
US20220307001A1
(en)
|
2018-02-27 |
2022-09-29 |
President And Fellows Of Harvard College |
Evolved cas9 variants and uses thereof
|
US10507226B1
(en)
|
2018-05-02 |
2019-12-17 |
University Of South Florida |
N-amino peptide beta-sheet mimics for the treatment of Alzheimer's disease
|
AU2019266326A1
(en)
|
2018-05-11 |
2020-11-26 |
Beam Therapeutics Inc. |
Methods of editing single nucleotide polymorphism using programmable base editor systems
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
EP3826670A1
(de)
|
2018-07-23 |
2021-06-02 |
Siwa Corporation |
Verfahren und zusammensetzungen zur behandlung chronischer effekte von strahlung und chemischer exposition
|
US20240173430A1
(en)
|
2018-09-05 |
2024-05-30 |
The Broad Institute, Inc. |
Base editing for treating hutchinson-gilford progeria syndrome
|
WO2020056345A1
(en)
|
2018-09-14 |
2020-03-19 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
US20220282275A1
(en)
|
2018-11-15 |
2022-09-08 |
The Broad Institute, Inc. |
G-to-t base editors and uses thereof
|
WO2020181195A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenine excision
|
WO2020181202A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to t:a base editing through adenine deamination and oxidation
|
US20220170013A1
(en)
|
2019-03-06 |
2022-06-02 |
The Broad Institute, Inc. |
T:a to a:t base editing through adenosine methylation
|
WO2020181178A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
T:a to a:t base editing through thymine alkylation
|
WO2020181180A1
(en)
|
2019-03-06 |
2020-09-10 |
The Broad Institute, Inc. |
A:t to c:g base editors and uses thereof
|
DE112020001342T5
(de)
|
2019-03-19 |
2022-01-13 |
President and Fellows of Harvard College |
Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen
|
US20220204975A1
(en)
|
2019-04-12 |
2022-06-30 |
President And Fellows Of Harvard College |
System for genome editing
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
EP3973054A1
(de)
|
2019-05-20 |
2022-03-30 |
The Broad Institute Inc. |
Aav-abgabe von nukleobasen-editoren
|
US20220315906A1
(en)
|
2019-08-08 |
2022-10-06 |
The Broad Institute, Inc. |
Base editors with diversified targeting scope
|
WO2021030666A1
(en)
|
2019-08-15 |
2021-02-18 |
The Broad Institute, Inc. |
Base editing by transglycosylation
|
WO2021050512A1
(en)
|
2019-09-09 |
2021-03-18 |
Beam Therapeutics Inc. |
Novel crispr enzymes, methods, systems and uses thereof
|
WO2021072328A1
(en)
|
2019-10-10 |
2021-04-15 |
The Broad Institute, Inc. |
Methods and compositions for prime editing rna
|
WO2021108717A2
(en)
|
2019-11-26 |
2021-06-03 |
The Broad Institute, Inc |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
WO2021113494A1
(en)
|
2019-12-03 |
2021-06-10 |
Beam Therapeutics Inc. |
Synthetic guide rna, compositions, methods, and uses thereof
|
CA3166153A1
(en)
|
2020-01-28 |
2021-08-05 |
The Broad Institute, Inc. |
Base editors, compositions, and methods for modifying the mitochondrial genome
|
US20230108687A1
(en)
|
2020-02-05 |
2023-04-06 |
The Broad Institute, Inc. |
Gene editing methods for treating spinal muscular atrophy
|
WO2021158921A2
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
EP4143315A1
(de)
|
2020-04-28 |
2023-03-08 |
The Broad Institute Inc. |
<smallcaps/>?ush2a? ?gezielte basisbearbeitung eines thegens
|
IL297799A
(en)
|
2020-05-01 |
2022-12-01 |
Siwa Corp |
Methods for treating infections
|
EP4146804A1
(de)
|
2020-05-08 |
2023-03-15 |
The Broad Institute Inc. |
Verfahren und zusammensetzungen zur gleichzeitigen bearbeitung beider stränge einer doppelsträngigen zielnukleotidsequenz
|
WO2022093195A1
(en)
|
2020-10-27 |
2022-05-05 |
Siwa Corporation |
Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens
|
WO2022094051A2
(en)
|
2020-10-28 |
2022-05-05 |
Children's Medical Center Corporation |
Truncated modified recombinant adamts13 and uses thereof
|
WO2022125776A2
(en)
|
2020-12-09 |
2022-06-16 |
Siwa Corporation |
Methods and compositions for treating kidney diseases
|
EP4263825A1
(de)
|
2021-02-19 |
2023-10-25 |
Beam Therapeutics, Inc. |
Rekombinante tollwutviren für gentherapie
|
CN117529555A
(zh)
|
2021-03-23 |
2024-02-06 |
比姆医疗股份有限公司 |
新颖crispr酶、方法、系统及其用途
|
WO2022221699A1
(en)
|
2021-04-16 |
2022-10-20 |
Beam Therapeutics, Inc. |
Genetic modification of hepatocytes
|
WO2022256578A2
(en)
|
2021-06-02 |
2022-12-08 |
Beam Therapeutics Inc. |
Circular guide rnas for crispr/cas editing systems
|
WO2022261509A1
(en)
|
2021-06-11 |
2022-12-15 |
The Broad Institute, Inc. |
Improved cytosine to guanine base editors
|
KR20240037299A
(ko)
|
2021-07-23 |
2024-03-21 |
빔 테라퓨틱스, 인크. |
Crispr/cas 편집 시스템용 가이드 rna
|
WO2023023654A1
(en)
|
2021-08-20 |
2023-02-23 |
Siwa Corporation |
Methods and compositions for treating fibrotic diseases
|
AU2022343725A1
(en)
|
2021-09-08 |
2024-03-21 |
Beam Therapeutics Inc. |
Viral guide rna delivery
|
WO2023076898A1
(en)
|
2021-10-25 |
2023-05-04 |
The Broad Institute, Inc. |
Methods and compositions for editing a genome with prime editing and a recombinase
|
AU2022395500A1
(en)
|
2021-11-23 |
2024-05-23 |
Cellectis Sa |
New tale protein scaffolds with improved on-target/off-target activity ratios
|
CA3238778A1
(en)
|
2021-12-03 |
2023-06-08 |
David R. Liu |
Self-assembling virus-like particles for delivery of nucleic acid programmable fusion proteins and methods of making and using same
|
WO2023102538A1
(en)
|
2021-12-03 |
2023-06-08 |
The Broad Institute, Inc. |
Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
|
CA3240917A1
(en)
|
2021-12-17 |
2023-06-22 |
Bernd ZETSCHE |
Crispr enzymes, methzods, systems and uses thereof
|
WO2023196802A1
(en)
|
2022-04-04 |
2023-10-12 |
The Broad Institute, Inc. |
Cas9 variants having non-canonical pam specificities and uses thereof
|
WO2023196772A1
(en)
|
2022-04-04 |
2023-10-12 |
Beam Therapeutics Inc. |
Novel rna base editing compositions, systems, methods and uses thereof
|
WO2023205687A1
(en)
|
2022-04-20 |
2023-10-26 |
The Broad Institute, Inc. |
Improved prime editing methods and compositions
|
WO2023212715A1
(en)
|
2022-04-28 |
2023-11-02 |
The Broad Institute, Inc. |
Aav vectors encoding base editors and uses thereof
|
WO2023230613A1
(en)
|
2022-05-27 |
2023-11-30 |
The Broad Institute, Inc. |
Improved mitochondrial base editors and methods for editing mitochondrial dna
|
WO2023240137A1
(en)
|
2022-06-08 |
2023-12-14 |
The Board Institute, Inc. |
Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
|
WO2024040083A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
Evolved cytosine deaminases and methods of editing dna using same
|
WO2024059791A1
(en)
|
2022-09-16 |
2024-03-21 |
Beam Therapeutics Inc. |
Large serine recombinases, systems and uses thereof
|
WO2024077267A1
(en)
|
2022-10-07 |
2024-04-11 |
The Broad Institute, Inc. |
Prime editing methods and compositions for treating triplet repeat disorders
|
WO2024102157A1
(en)
|
2022-11-09 |
2024-05-16 |
Siwa Corporation |
Methods and compositions for treating diabetes and diabetic complications
|
WO2024138087A2
(en)
|
2022-12-23 |
2024-06-27 |
The Broad Institute, Inc. |
Methods and compositions for modulating cellular factors to increase prime editing efficiencies
|